SG Americas Securities’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,917
Closed -$79K 3601
2025
Q1
$79K Sell
15,917
-4,439
-22% -$14.1K ﹤0.01% 3118
2024
Q4
$60K Buy
20,356
+3,466
+21% +$14.2K ﹤0.01% 2874
2024
Q3
$80K Buy
+16,890
New +$76.2K ﹤0.01% 3138
2024
Q2
Sell
-17,441
Closed -$93K 3318
2024
Q1
$93K Sell
17,441
-9,874
-36% -$46.4K ﹤0.01% 2587
2023
Q4
$117K Buy
27,315
+4,715
+21% +$14.5K ﹤0.01% 2644
2023
Q3
$89K Buy
+22,600
New +$148K ﹤0.01% 2823
2023
Q2
Sell
-15,056
Closed -$154K 3168
2023
Q1
$154K Buy
15,056
+1,523
+11% +$17.4K ﹤0.01% 2617
2022
Q4
$127K Buy
13,533
+1,881
+16% +$26.5K ﹤0.01% 2552
2022
Q3
$170K Sell
11,652
-17,176
-60% -$255K ﹤0.01% 2444
2022
Q2
$381K Buy
+28,828
New +$393K ﹤0.01% 2190
2022
Q1
Sell
-10,946
Closed -$281K 3441
2021
Q4
$281K Buy
+10,946
New +$341K ﹤0.01% 2482

Other funds holding TSVT

SG Americas Securities's TSVT Position: Q2 2025 in Review

SG Americas Securities sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 15,917 shares — an estimated $79K sold.

SG Americas Securities first reported a position in TSVT in Q4 2021 and held it in 11 quarters. The position peaked at $381K in Q2 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • SG Americas Securities reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 15,917 2seventy bio shares in Q2 2025, an estimated $79K.
  • SG Americas Securities first reported a position in 2seventy bio in Q4 2021 and held it in 11 quarters.
  • SG Americas Securities's 2seventy bio position peaked at $381K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.